Personalis, Inc. Net Fee Amt
Personalis, Inc. (PSNL) had Net Fee Amt of $0 as of 2026-08-31, per its SC 13E3 filed 2026-08-31.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-31
- 2026-08-31: Net Fee Amt $0.00.
- 2026-05-07: Net Fee Amt $20.71K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-31 | $0.00 SC 13E3 · filed 2026-08-31 |
| 2026-05-07 | $20.71K S-3ASR · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |